Gravity Analytica

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

CBLL 12.23.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2025-01-13

Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference

Full Press Release SEC Filings Our CBLL Tweets

About Gravity Analytica

Recent Filings

SUNNYVALE, Calif.,Dec. 23, 2024(GLOBE NEWSWIRE) --Ceribell, Inc.(Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced thatJane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 43^rdAnnualJ.P. Morgan Healthcare Conference. The presentation will take place onMonday, January 13, 2025, at7:30 a.m. Pacific Standard Time.

Event: 43^rdAnnualJ.P. Morgan Healthcare ConferenceDate:Monday, January 13, 2025Time: 7:30 a.m. PST

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website athttps://investors.ceribell.com/.

AboutCeribell, Inc.Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across theU.S.Ceribell is headquartered inSunnyvale, California. For more information, please visitwww.ceribell.comor follow the company onLinkedIn.

Investor ContactBrian JohnstonorLaine MorganGilmartin GroupInvestors@ceribell.com

Media ContactCorrie RosePress@ceribell.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com